These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9697778)

  • 1. Screening digital rectal examination and prostate cancer mortality: a population-based case-control study.
    Jacobsen SJ; Bergstralh EJ; Katusic SK; Guess HA; Darby CH; Silverstein MD; Oesterling JE; Lieber MM
    Urology; 1998 Aug; 52(2):173-9. PubMed ID: 9697778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based case-control study of PSA and DRE screening on prostate cancer mortality.
    Bergstralh EJ; Roberts RO; Farmer SA; Slezak JM; Lieber MM; Jacobsen SJ
    Urology; 2007 Nov; 70(5):936-41. PubMed ID: 18068451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening digital rectal examination and prostate cancer mortality: a case-control study.
    Richert-Boe KE; Humphrey LL; Glass AG; Weiss NS
    J Med Screen; 1998; 5(2):99-103. PubMed ID: 9718529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study.
    Weinmann S; Richert-Boe KE; Van Den Eeden SK; Enger SM; Rybicki BA; Shapiro JA; Weiss NS
    Epidemiology; 2005 May; 16(3):367-76. PubMed ID: 15824554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.
    Roberts RO; Bergstralh EJ; Lieber MM; Jacobsen SJ
    Urology; 2000 Nov; 56(5):817-22. PubMed ID: 11068309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening and mortality: a case-control study (United States).
    Weinmann S; Richert-Boe K; Glass AG; Weiss NS
    Cancer Causes Control; 2004 Mar; 15(2):133-8. PubMed ID: 15017125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of screening for prostate cancer: a nested case-control study.
    Concato J; Wells CK; Horwitz RI; Penson D; Fincke G; Berlowitz DR; Froehlich G; Blake D; Vickers MA; Gehr GA; Raheb NH; Sullivan G; Peduzzi P
    Arch Intern Med; 2006 Jan; 166(1):38-43. PubMed ID: 16401808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.
    Shim HB; Lee SE; Park HK; Ku JH
    Prostate Cancer Prostatic Dis; 2007; 10(3):250-5. PubMed ID: 17297501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council.
    Crawford ED; DeAntoni EP; Etzioni R; Schaefer VC; Olson RM; Ross CA
    Urology; 1996 Jun; 47(6):863-9. PubMed ID: 8677578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.
    Wallner LP; Sarma AV; Lieber MM; St Sauver JL; Jacobson DJ; McGree ME; Gowan ME; Jacobsen SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3588-92. PubMed ID: 19064575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
    Tourville EA; Nguyen MM
    Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
    Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control study.
    Bunting PS; Neuman J; Goel V; Fleshner N; Kopec J; Levers P; Warde P
    J Clin Epidemiol; 2005 Jun; 58(6):639-44. PubMed ID: 15878478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
    Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.